Hansa Biopharma announces study design for a US randomized, controlled trial of imlifidase in ...

Retrieved on: 2021-06-23 08:37:30

Tags for this article:

Click the tags to see associated articles and topics

Hansa Biopharma announces study design for a US randomized, controlled trial of imlifidase in .... View article details on hiswai:

Excerpt

LUND, Sweden, June 23, 2021 /PRNewswire/ -- Hansa Biopharma AB "Hansa", (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare ...

Article found on: www.prnewswire.com